What is NAGE's pharmaceuticals segment — selling?

NAGE (NAGE) reported pharmaceuticals segment — selling of $0 in Q1 2026.

What does pharmaceuticals segment — selling mean?

Includes the costs associated with the sales force, distribution, and customer relationship management within the pharmaceutical segment. This metric captures the operational investment required to bring products to market and maintain customer accounts. It is a critical component of the segment's overall selling, general, and administrative cost structure.

NAGE NAGE Pharmaceuticals segment — Selling

Other segment segments

Consumer Products segment

$2.73M+8.8%

Ingredients segment

$94K+91.8%

Analytical Reference Standards and Services segment

$44K-58.9%

Similar metrics at other companies

BLCOPharmaceuticals — Selling, general and administrative (Note 4)

$138M-9.8%

BAXPharmaceuticals — Selling, general and administrative expenses

$102M-1.0%

BAXPharmaceuticals — Cost of Sales

$458M+15.7%

VRTXPharmaceuticals — Selling and other commercial expenses

$313.6M+30.1%

ARDXReportable Segment — Selling

$67.4M+18.7%

SLQTSenior Segment — Cost of goods sold—pharmacy revenue

$0—

Other financials

Income statement

See full

Revenue$31.5M+3.3%

Gross profit$20.0M+3.3%

Operating income$1.6M-67.0%

Net income$6.3M+24.8%

EPS (diluted)$0.07+16.7%

Balance sheet

See full

Cash & equivalents$66.5M+19.7%

Total debt$2.6M-26.9%

Total equity$82.3M+48.8%

Total assets$114.3M+40.6%

Cash flow

See full

Operating cash flow-$1.2M-115%

Valuation

See full

Market cap$254.07M-74.9%

Enterprise value$190.09M-79.7%

P/E13.6×-43.5×

P/S2×-6.8×

Profitability

See full

Gross margin64.3%+1.8pp

Operating margin10%-2.2pp

Net margin14.3%+1.2pp

FCF margin-70.4%—

Returns & leverage

See full

Return on equity27.1%-6.4pp

Debt / equity0×0.0×

Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:SellingExpense.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's pharmaceuticals segment — selling.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NAGE's pharmaceuticals segment — selling?: NAGE (NAGE) reported pharmaceuticals segment — selling of $0 in Q1 2026.
What does pharmaceuticals segment — selling mean?: Includes the costs associated with the sales force, distribution, and customer relationship management within the pharmaceutical segment. This metric captures the operational investment required to bring products to market and maintain customer accounts. It is a critical component of the segment's overall selling, general, and administrative cost structure.